DEUTSCHE BANK AG\
BankPosition in TVTX — Travere Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in TVTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,815,369
-$14,693,683 QoQ
Shares Held
225,583
-75.6% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. TVTX ranks #34 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in TVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,815,369 | 225,583 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $27,509,052 | 925,919 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $33,688,992 | 881,680 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $38,223,150 | 1,599,295 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,644,909 | 516,548 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,421,815 | 525,771 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $9,267,979 | 532,031 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $9,444,438 | 675,085 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $7,781,059 | 946,601 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $18,516,127 | 2,401,573 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $21,582,895 | 2,400,767 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,757,596 | 308,456 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $6,520,949 | 424,541 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,723,409 | 476,808 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,813,259 | 276,427 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,077,803 | 327,833 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,211,019 | 545,234 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $14,793,112 | 574,044 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,342,930 | 397,646 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $8,265,538 | 340,847 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $4,988,742 | 341,929 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $11,150,827 | 446,569 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $12,108,877 | 444,281 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 RTRX | — | 436,160 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 RTRX | — | 431,442 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 RTRX | — | 418,347 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||